Neupulse has secured £2.5 million funding to commercialise the world’s first wearable device to tackle Tourette Syndrome. The University of Nottingham spinout, which featured on our sister publication TechBlast’s recent Nottingham Startups 2.0 list, is also targeting other tic disorders and is moving towards regulatory approval in the UK, Europe, and the USA. Neupulse’s recently … Continue reading Nottingham Startups 2.0 firm secures £2.5m to tackle Tourette’s